Structure-function analysis reveals the molecular determinants of the impaired biological function of DAX-1 mutants in AHC patients

被引:36
作者
Lehmann, SG [1 ]
Wurtz, JM [1 ]
Renaud, JP [1 ]
Sassone-Corsi, P [1 ]
Lalli, E [1 ]
机构
[1] Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France
关键词
D O I
10.1093/hmg/ddg108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the DAX-1 (NR0B1) gene cause the X-linked form of adrenal hypoplasia congenita (AHC), which is constantly found associated with hypogonadotropic hypogonadism (HHG). DAX-1 encodes an atypical orphan member of the nuclear hormone receptor superfamily. DAX-1 acts at multiple levels to repress the expression of genes involved in steroid hormone metabolism through a potent transcriptional repression domain present in its C-terminus, which is similar to the nuclear receptors ligand binding domain. All DAX-1 mutations causing AHC/HHG alter the protein C-terminal domain, impairing its nuclear localization and, consequently, its transcriptional repression activity. Here we show that DAX-1 AHC mutants have a misfolded conformation, which correlates with their cytoplasmic retention. Extensive structure-function analysis reveals that the chemical nature of amino, acid residues at positions interested by AHC mutations and critical determinants in helix 12 affect DAX-1 nuclear localization and transcriptional silencing. Surprisingly, mutations in a conserved putative corepressor binding surface have a negative effect upon DAX-1 transcriptional repression only when they also affect protein expression levels. These data suggest that a folding defect underlies the impaired function of DAX-1 missense mutants found in AHC/HHG patients and that interactions with transcriptional cofactors different from known corepressors mediate DAX-1 silencing properties.
引用
收藏
页码:1063 / 1072
页数:10
相关论文
共 41 条
[1]  
ALLAN GF, 1992, J BIOL CHEM, V267, P19513
[2]   A DOSAGE SENSITIVE LOCUS AT CHROMOSOME XP21 IS INVOLVED IN MALE TO FEMALE SEX REVERSAL [J].
BARDONI, B ;
ZANARIA, E ;
GUIOLI, S ;
FLORIDIA, G ;
WORLEY, KC ;
TONINI, G ;
FERRANTE, E ;
CHIUMELLO, G ;
MCCABE, ERB ;
FRACCARO, M ;
ZUFFARDI, O ;
CAMERINO, G .
NATURE GENETICS, 1994, 7 (04) :497-501
[3]   CHARACTERIZATION OF THE LIGAND-DEPENDENT TRANSACTIVATION DOMAIN OF THYROID-HORMONE RECEPTOR [J].
BARETTINO, D ;
RUIZ, MDMV ;
STUNNENBERG, HG .
EMBO JOURNAL, 1994, 13 (13) :3039-3049
[4]   IDENTIFICATION OF A CONSERVED REGION REQUIRED FOR HORMONE DEPENDENT TRANSCRIPTIONAL ACTIVATION BY STEROID-HORMONE RECEPTORS [J].
DANIELIAN, PS ;
WHITE, R ;
LEES, JA ;
PARKER, MG .
EMBO JOURNAL, 1992, 11 (03) :1025-1033
[5]   Protein misfolding, evolution and disease [J].
Dobson, CM .
TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (09) :329-332
[6]   ACTIVATION FUNCTION-2 (AF-2) OF RETINOIC ACID RECEPTOR AND 9-CIS RETINOIC ACID RECEPTOR - PRESENCE OF A CONSERVED AUTONOMOUS CONSTITUTIVE ACTIVATING DOMAIN AND INFLUENCE OF THE NATURE OF THE RESPONSE ELEMENT ON AF-2 ACTIVITY [J].
DURAND, B ;
SAUNDERS, M ;
GAUDON, C ;
ROY, B ;
LOSSON, R ;
CHAMBON, P .
EMBO JOURNAL, 1994, 13 (22) :5370-5382
[7]   SETOR - HARDWARE-LIGHTED 3-DIMENSIONAL SOLID MODEL REPRESENTATIONS OF MACROMOLECULES [J].
EVANS, SV .
JOURNAL OF MOLECULAR GRAPHICS, 1993, 11 (02) :134-&
[8]   Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors [J].
Feng, WJ ;
Ribeiro, RCJ ;
Wagner, RL ;
Nguyen, H ;
Apriletti, JW ;
Fletterick, RJ ;
Baxter, JD ;
Kushner, PJ ;
West, BL .
SCIENCE, 1998, 280 (5370) :1747-1749
[9]   Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis [J].
Gelman, MS ;
Kopito, RR .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (11) :1591-1597
[10]  
Glass CK, 2000, GENE DEV, V14, P121